HOOKIPA Pharma
(OTC) HOOK
HOOKIPA Pharma Financials at a Glance
Market Cap
$12.95M
Revenue (TTM)
$14.86M
Net Income (TTM)
$56.00M
EPS (TTM)
$-4.54
P/E Ratio
-0.23
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$1.05
Volume
8,244
Open
$1.04
Price
$1.05
Volume
8,244
Open
$1.04
Previous Close
$1.05
Daily Range
$1.01 - $1.08
52-Week Range
$0.72 - $1.77
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$1.05
Volume
8,244
Open
$1.04
Previous Close
$1.05
Daily Range
$1.01 - $1.08
52-Week Range
$0.72 - $1.77
HOOK News
HOOK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout HOOKIPA Pharma
Industry
Biotechnology
Sector
Health CareEmployees
20
CEO
Malte Peters, MD
Website
www.hookipapharma.comHeadquarters
New York City, NY 10118, US
HOOK Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-98%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-4.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.95M
Shares Outstanding
12.33M
Volume
8.24K
Short Interest
0.00%
Avg. Volume
10.12K
Financials (TTM)
Gross Profit
$41.19M
Operating Income
$51.45M
EBITDA
$40.85M
Operating Cash Flow
$76.98M
Capital Expenditure
$194.00K
Free Cash Flow
$77.17M
Cash & ST Invst.
$39.68M
Total Debt
$875.00K
HOOKIPA Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.79M
+426.7%
Gross Profit
$6.79M
+426.7%
Gross Margin
100.00%
N/A
Market Cap
$12.95M
N/A
Market Cap/Employee
$157.89K
N/A
Employees
82
N/A
Net Income
$1.79M
+90.6%
EBITDA
$1.32M
+92.8%
Quarterly Fundamentals
Net Cash
$33.68M
-53.4%
Accounts Receivable
$9.50M
-57.9%
Inventory
$0.00
N/A
Long Term Debt
$298.00K
-91.2%
Short Term Debt
$248.00K
-91.8%
Return on Assets
-1.06%
N/A
Return on Invested Capital
-1.63%
N/A
Free Cash Flow
$7.13M
+50.5%
Operating Cash Flow
$7.13M
+50.4%